JW Pharmaceutical (XKRX:001065.PFD) Beginning Cash Position : ₩10,429.54 Mil (As of Mar. 2025)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Beginning Cash Position?

JW Pharmaceutical's Beginning Cash Position for the quarter that ended in Mar. 2025 was ₩10,429.54 Mil.

JW Pharmaceutical's quarterly Beginning Cash Position increased from Sep. 2024 (₩33,282.36 Mil) to Dec. 2024 (₩38,774.83 Mil) but then declined from Dec. 2024 (₩38,774.83 Mil) to Mar. 2025 (₩10,429.54 Mil).

JW Pharmaceutical's annual Beginning Cash Position increased from Dec. 2022 (₩33,366.48 Mil) to Dec. 2023 (₩33,897.93 Mil) but then declined from Dec. 2023 (₩33,897.93 Mil) to Dec. 2024 (₩15,908.87 Mil).

JW Pharmaceutical Beginning Cash Position Historical Data

The historical data trend for JW Pharmaceutical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Beginning Cash Position Chart

JW Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

41,864.25

10,451.34

33,366.48

33,897.93

15,908.87

JW Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															15,908.87	32,684.03	33,282.36	38,774.83	10,429.54

JW Pharmaceutical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

JW Pharmaceutical Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001065.PFD) » Definitions » Beginning Cash Position

Traded in Other Exchanges

001067:Korea 001060:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines